enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Lutetium (177Lu) oxodotreotide - Wikipedia

   en.wikipedia.org/wiki/Lutetium_(177Lu)_oxodotreotide

   Lutetium (177 Lu) oxodotreotide or 177 Lu dotatate, brand name Lutathera, is a chelated complex of a radioisotope of the element lutetium with dotatate, used in peptide receptor radionuclide therapy. Specifically, it is used in the treatment of cancers which express somatostatin receptors. [5] It is a radiolabeled somatostatin analog. [3] [6] [7]

3. DOTA-TATE - Wikipedia

   en.wikipedia.org/wiki/DOTA-TATE

   DOTA-TATE can be reacted with the radionuclides gallium-68 (T 1/2 = 68 min), lutetium-177 (T 1/2 = 6.65 d) and copper-64 (T 1/2 = 12.7 h) to form radiopharmaceuticals for positron emission tomography (PET) imaging or radionuclide therapy. 177 Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets ...

4. Peptide receptor radionuclide therapy - Wikipedia

   en.wikipedia.org/wiki/Peptide_receptor...

   Radiation from lutetium (177 Lu) oxodotreotide can cause damage when the medicine passes through tubules in the kidney. [45] Arginine/lysine can be used to reduce renal radiation exposure during peptide receptor radionuclide therapy with lutetium ( 177 Lu) oxodotreotide.

5. Lutetium (177Lu) vipivotide tetraxetan - Wikipedia

   en.wikipedia.org/wiki/Lutetium_(177Lu)_vipivot...

   Lutetium (177 Lu) vipivotide tetraxetan, sold under the brand name Pluvicto, is a radiopharmaceutical medication used for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). [5] [6] Lutetium (177 Lu) vipivotide tetraxetan is a targeted radioligand therapy. [6] [8]

6. Isotopes of lutetium - Wikipedia

   en.wikipedia.org/wiki/Isotopes_of_lutetium

   Forty radioisotopes have been characterized, with the most stable, besides 176 Lu, being 174 Lu with a half-life of 3.31 years, and 173 Lu with a half-life of 1.37 years. All of the remaining radioactive isotopes have half-lives that are less than 9 days, and the majority of these have half-lives that are less than half an hour.

7. Edotreotide - Wikipedia

   en.wikipedia.org/wiki/Edotreotide

   Lutetium-177 labelled edotreotide (177 Lu-DOTA-TOC), with the trade name Solucin, is the subject of a phase 3 clinical trial for treatment of GEP-NETs. [ 7 ] [ 8 ] It was granted orphan drug designation by the European Medicines Agency in 2014.